The MHRA Papers - Part 25
We had some questions, but not the mystery ones, as it turned out.
In the second article of the MHRA papers series, we reported that the MHRA Secret Squirrels Commission On Human Medicines (CHM) COVID-19 Vaccines Benefit Risk Expert Working Group had compiled 36 questions for the manufacturers of Covid-19 vaccine BNT162b2 (Cominarty).
The MHRA Papers - Part 2
·
We continue reviewing the minutes of the three meetings of the MHRA’s Commission On Human Medicines (CHM) COVID-19 Vaccines Benefit Risk Expert Working Group, which took place between 28 October and 18 November 2020.
The squirrels also asked their handlers whether pharma had a formal obligation to repl…